AddBIO signs with CSL Behring
AddBIO have signed an agreement with the pharmaceutical company CSL Behring GmbH, to supply us with the highly pure blood protein concentrate used in the in Zolidd coating. “We look forward to a long-term collaboration with CSL Behring, a global biotherapeutics leader that has served the market with therapeutic blood derivatives for more than a century”, says Ulf Sewerin CEO at AddBIO.